Exploring Gen AI in the Pharmaceutical Industry

Gen AI in pharma is an emerging field that leverages AI to enhance various aspects of the pharmaceutical industry.

GenAI holds potential across the pharma value chain. Activity has largely focused on drug discovery and development, with GenAI being leveraged to accelerate the process of de novo drug design, as well as drug repurposing or target identification. Many other opportunities exist across the pharma value chain to incorporate GenAI including in clinical trials to automate clinical trial documentation processes, in supply chain and manufacturing to enhance training processes, in commercial to personalise patient engagement, and in medical affairs for medical content generation and insight generation. 

This serves as a foundation for further exploration and development of AI solutions in healthcare. 

Join this session to hear case studies on GenAI in Pharma: 

• Where along the value chain is the application of GenAI most mature?
• What are some successful case studies of the application of GenAI in the pharmaceutical industry? 
• What is the ‘next frontier’ of GenAI in pharma? What are pharmaceutical companies experimenting with?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.